Literature DB >> 10738084

Telemedicine in radiotherapy treatment planning: requirements and applications.

D R Olsen1, S Bruland, B J Davis.   

Abstract

BACKGROUND AND
PURPOSE: Telemedicine facilitates decentralized radiotherapy services by allowing remote treatment planning and quality assurance of treatment delivery. A prerequisite is digital storage of relevant data and an efficient and reliable telecommunication system between satellite units and the main radiotherapy clinic. The requirements of a telemedicine system in radiotherapy is influenced by the level of support needed. In this paper we differentiate between three categories of telemedicine support in radiotherapy. RESULTS AND DISCUSSION: Level 1 features video conferencing and display of radiotherapy images and dose plans. Level 2 involves replication of selected data from the radiotherapy database - facilitating remote treatment planning and evaluation. Level 3 includes real-time, remote operations, e.g. target volume delineation and treatment planning performed by the team at the satellite unit under supervision and guidance from more experienced colleagues at the main clinic.

Mesh:

Year:  2000        PMID: 10738084     DOI: 10.1016/s0167-8140(99)00185-1

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Teleoncology: current and future applications for improving cancer care globally.

Authors:  Ribhi Hazin; Ibrahim Qaddoumi
Journal:  Lancet Oncol       Date:  2010-02       Impact factor: 41.316

2.  A telemedicine application to schedule temperature in an in vivo sensor network for cancer treatment.

Authors:  Rossi Kamal; Choong Seon Hong; Seok-Geun Lee
Journal:  Telemed J E Health       Date:  2012-12       Impact factor: 3.536

3.  Decentralisation of radiation therapy. Is it possible and beneficial to patients? Experience of the first 5 years of a satellite radiotherapy unit in the province of Tarragona, Spain.

Authors:  Meritxell Arenas; David Gomez; Sebastià Sabater; Angeles Rovirosa; Albert Biete; Jordi Colomer
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-08

4.  Planning of electroporation-based treatments using Web-based treatment-planning software.

Authors:  Denis Pavliha; Bor Kos; Marija Marčan; Anže Zupanič; Gregor Serša; Damijan Miklavčič
Journal:  J Membr Biol       Date:  2013-06-19       Impact factor: 1.843

5.  Training the trainees in radiation oncology with telemedicine as a tool in a developing country: a two-year audit.

Authors:  Sushma Agrawal; Anil Kumar Maurya; Kirti Shrivastava; Shaleen Kumar; M C Pant; Saroj Kant Mishra
Journal:  Int J Telemed Appl       Date:  2011-04-26

6.  Telehealth in radiation oncology at the Townsville Cancer Centre: Service evaluation and patient satisfaction.

Authors:  Elizabeth Hamilton; Ellie Van Veldhuizen; Amy Brown; Sean Brennan; Sabe Sabesan
Journal:  Clin Transl Radiat Oncol       Date:  2018-11-20

7.  A client-server framework for 3D remote visualization of radiotherapy treatment space.

Authors:  Anand P Santhanam; Yugang Min; Tai H Dou; Patrick Kupelian; Daniel A Low
Journal:  Front Oncol       Date:  2013-02-22       Impact factor: 6.244

8.  Teleradiotherapy Network: Applications and Feasibility for Providing Cost-Effective Comprehensive Radiotherapy Care in Low- and Middle-Income Group Countries for Cancer Patients.

Authors:  Niloy Ranjan Datta; Michael Heuser; Massoud Samiei; Ragesh Shah; Gerd Lutters; Stephan Bodis
Journal:  Telemed J E Health       Date:  2015-03-12       Impact factor: 3.536

9.  Opportunities in Telemedicine, Lessons Learned After COVID-19 and the Way Into the Future.

Authors:  May Abdel-Wahab; Eduardo Rosenblatt; Ben Prajogi; Eduardo Zubizarretta; Miriam Mikhail
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-10-01       Impact factor: 7.038

10.  "Connection Failed": A Word of Caution on Telemedicine in Radiation Oncology.

Authors:  Tobias Finazzi; Alexandros Papachristofilou; Frank Zimmermann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-10-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.